1Kreger BE,Craven DE,Carling PC.Gram-negative bacteremia.Reassessment of etiology,epidemiology and ecology in 612 patients.Am J Med,1980,68:332-343.
2Kuikka A,Valtonen VV.Factors associated with improved outcome of pseudomonas aeruginosa bacteremia in a Finnish university hospital.Eur J Clin Microbiol Dis,1998,17:701-708.
3Soen GG,Geva LL,Keller N,et al.Pseudomonas aeruginosa bacteremia in children:analysis of trends in prevalence,antibiotic resistance and prognostic factors.Pediatri Infect Dis J,2000,19:959-963.
4Huang YC,Lin TY,Wang CH.Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children:analysis of forty-three episodes.Pediatri Infect Dis J,2002,21:1049-1052.
5Wu BY,Peng CT,Tsai CH,et al.Community-acquired pseudomonas aeruginosa bacteremia and sepsis in previously healthy infants.Acta Paediatr Taiwan.1999,40:233-236.
6Aliaga L,Mediavilla JD,Cobo F.Clinical index predicting mortality with pseudomonas aeruginosa bacteremia.J Med Microbiol,2002,51:615-619.
7Enarson PM,Gie RP,Mwansambo CC,et al. Reducingdeaths from severe pneumonia in children in Malawi by improving delivery of pneumonia case management[J]. PLoSOne,2014,9(7):e102955.
8Tagami T,Matsui H,Horiguchi H,et al. Antithrombin andmortality in severe pneumonia patients with sepsisassociateddisseminated intravascular coagulation:an observational nationwide study [J]. J Thromb Haemost,2014,12 (9 ):1470 -1479.
9Sugimoto K,Adomi S,Koike H,et al. Procalcitonin as anindicator of urosepsis[J]. Res Rep Urol,2013,5:77 -80.
10Powell B,Smith I. The diagnostic role of procalcitonin inquinineinduced disseminated intravascular coagulation[J].Anaesth Intensive Care,2013,41(1):131 -132.
